Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,579 | 539 | 98.7% |
| Education | $111.57 | 13 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,445 | 94 | $0 (2024) |
| ABBVIE INC. | $1,039 | 87 | $0 (2024) |
| Amgen Inc. | $963.49 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $691.79 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $417.52 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $391.02 | 27 | $0 (2023) |
| Allergan, Inc. | $364.74 | 33 | $0 (2020) |
| Lilly USA, LLC | $363.44 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $276.13 | 23 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $269.70 | 19 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $721.35 | 34 | Novo Nordisk Inc ($164.59) |
| 2023 | $1,176 | 65 | ABBVIE INC. ($247.46) |
| 2022 | $775.96 | 60 | ABBVIE INC. ($187.32) |
| 2021 | $1,739 | 115 | AbbVie Inc. ($525.86) |
| 2020 | $790.61 | 59 | Allergan, Inc. ($160.06) |
| 2019 | $1,037 | 50 | Janssen Pharmaceuticals, Inc ($219.53) |
| 2018 | $1,142 | 76 | Novo Nordisk Inc ($263.70) |
| 2017 | $1,309 | 93 | Novo Nordisk Inc ($254.34) |
All Payment Transactions
552 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Diabetes Care | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $54.73 | General |
| Category: NEUROLOGY | ||||||
| 05/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: PAIN | ||||||
| 05/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: PAIN | ||||||
| 04/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,079 | 6,883 | $457,183 | $248,888 |
| 2022 | 58 | 6,711 | 11,596 | $599,840 | $315,551 |
| 2021 | 53 | 7,497 | 13,236 | $703,033 | $391,447 |
| 2020 | 54 | 6,771 | 11,492 | $583,980 | $295,026 |
All Medicare Procedures & Services
202 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 364 | 1,001 | $150,150 | $91,076 | 60.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 330 | 535 | $119,305 | $64,405 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 248 | 464 | $55,680 | $29,002 | 52.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 443 | 1,019 | $10,190 | $8,560 | 84.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 301 | 412 | $20,600 | $6,782 | 32.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 81 | 106 | $6,042 | $5,330 | 88.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 399 | 692 | $10,380 | $5,266 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $9,620 | $4,780 | 49.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 308 | 461 | $11,525 | $4,771 | 41.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 240 | 285 | $7,125 | $3,715 | 52.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 14 | $4,900 | $3,093 | 63.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 66 | 66 | $2,798 | $1,915 | 68.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,750 | $1,794 | 65.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,480 | $1,751 | 50.3% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 123 | 125 | $2,582 | $1,738 | 67.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 175 | 194 | $8,536 | $1,707 | 20.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 34 | $4,760 | $1,462 | 30.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 23 | 28 | $3,360 | $1,289 | 38.4% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 70 | 87 | $3,045 | $1,205 | 39.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 94 | 101 | $1,515 | $961.52 | 63.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 22 | $1,210 | $917.84 | 75.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 48 | 48 | $1,296 | $908.16 | 70.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 81 | $2,835 | $858.85 | 30.3% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 16 | 19 | $1,140 | $730.93 | 64.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 188 | 331 | $3,310 | $728.20 | 22.0% |
About Dr. Richard Miller, MD
Dr. Richard Miller, MD is a Internal Medicine healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720062938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Miller, MD has received a total of $8,691 in payments from pharmaceutical and medical device companies, with $721.35 received in 2024. These payments were reported across 552 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,579).
As a Medicare-enrolled provider, Miller has provided services to 25,058 Medicare beneficiaries, totaling 43,207 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 202 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lynchburg, VA
- Active Since 12/01/2005
- Last Updated 12/10/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720062938
Products in Payments
- UBRELVY (Drug) $501.35
- Ozempic (Drug) $476.03
- VRAYLAR (Drug) $463.54
- XARELTO (Drug) $423.21
- Prolia (Biological) $405.51
- NURTEC ODT (Drug) $350.14
- Victoza (Drug) $270.34
- Aimovig (Biological) $267.34
- FARXIGA (Drug) $251.75
- NEXLETOL (Drug) $224.90
- Rybelsus (Drug) $156.35
- Tresiba (Drug) $154.52
- QULIPTA (Drug) $146.47
- EVENITY (Biological) $140.23
- MYRBETRIQ (Drug) $139.29
- Auvelity (Drug) $133.95
- DALVANCE (Drug) $128.89
- Kerendia (Drug) $128.68
- ENTRESTO (Drug) $125.41
- INSPIRE (Device) $122.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lynchburg
Dr. Julia Mchugh, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $31,277
Dr. Patrick Kenny, Do, DO
Internal Medicine — Payments: $10,141
Juan Aponte, Md, MD
Internal Medicine — Payments: $9,659
Dr. Kenneth Musana, Md, MD
Internal Medicine — Payments: $8,380
Dr. Evan Ownby, Md, MD
Internal Medicine — Payments: $3,602
Dr. Michael Cook, Md, MD
Internal Medicine — Payments: $3,493